Cargando…
Tyrosinemia type III in an asymptomatic girl
Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the HPD gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471395/ https://www.ncbi.nlm.nih.gov/pubmed/28649543 http://dx.doi.org/10.1016/j.ymgmr.2015.10.004 |
_version_ | 1783243941903073280 |
---|---|
author | Szymanska, Edyta Sredzinska, Malgorzata Ciara, Elzbieta Piekutowska-Abramczuk, Dorota Ploski, Rafal Rokicki, Dariusz Tylki-Szymanska, Anna |
author_facet | Szymanska, Edyta Sredzinska, Malgorzata Ciara, Elzbieta Piekutowska-Abramczuk, Dorota Ploski, Rafal Rokicki, Dariusz Tylki-Szymanska, Anna |
author_sort | Szymanska, Edyta |
collection | PubMed |
description | Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the HPD gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion of tyrosine derivatives into urine (www.orpha.net). Since it is the least frequent form of tyrosinemia, only few cases with the variable but rather mild clinical features have been described so far. We report an 11 year old girl presenting with no clinical symptoms and with normal mental development who has been diagnosed with HT3 through metabolic screening on the basis of elevated serum level of tyrosine ranging from 425 to 535 μmol/L (normal values: 29–86 μmol/L), and elevated urinary excretion of p-hydroxyphenyl derivatives confirmed genetically with the homozygous c.479A > G (p.Tyr160Cys) missense change in the HPD gene. The girl has been only presenting with recurrent proteinuria of unknown etiology. A phenylalanine- and tyrosine-restricted diet has never been administered. Presented case may suggest that high tyrosine concentration itself does not participate directly in neuronal damage described in patients with tyrosinemia type 3. |
format | Online Article Text |
id | pubmed-5471395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-54713952017-06-23 Tyrosinemia type III in an asymptomatic girl Szymanska, Edyta Sredzinska, Malgorzata Ciara, Elzbieta Piekutowska-Abramczuk, Dorota Ploski, Rafal Rokicki, Dariusz Tylki-Szymanska, Anna Mol Genet Metab Rep Case Report Tyrosinemia type 3 (HT3) is a rare inborn error of tyrosine metabolism caused by mutations in the HPD gene encoding 4-hydroxyphenyl-pyruvate dioxygenase, which is transmitted in an autosomal recessive trait. The disorder is characterized by tyrosine accumulation in body fluids and massive excretion of tyrosine derivatives into urine (www.orpha.net). Since it is the least frequent form of tyrosinemia, only few cases with the variable but rather mild clinical features have been described so far. We report an 11 year old girl presenting with no clinical symptoms and with normal mental development who has been diagnosed with HT3 through metabolic screening on the basis of elevated serum level of tyrosine ranging from 425 to 535 μmol/L (normal values: 29–86 μmol/L), and elevated urinary excretion of p-hydroxyphenyl derivatives confirmed genetically with the homozygous c.479A > G (p.Tyr160Cys) missense change in the HPD gene. The girl has been only presenting with recurrent proteinuria of unknown etiology. A phenylalanine- and tyrosine-restricted diet has never been administered. Presented case may suggest that high tyrosine concentration itself does not participate directly in neuronal damage described in patients with tyrosinemia type 3. Elsevier 2015-10-22 /pmc/articles/PMC5471395/ /pubmed/28649543 http://dx.doi.org/10.1016/j.ymgmr.2015.10.004 Text en © 2015 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Szymanska, Edyta Sredzinska, Malgorzata Ciara, Elzbieta Piekutowska-Abramczuk, Dorota Ploski, Rafal Rokicki, Dariusz Tylki-Szymanska, Anna Tyrosinemia type III in an asymptomatic girl |
title | Tyrosinemia type III in an asymptomatic girl |
title_full | Tyrosinemia type III in an asymptomatic girl |
title_fullStr | Tyrosinemia type III in an asymptomatic girl |
title_full_unstemmed | Tyrosinemia type III in an asymptomatic girl |
title_short | Tyrosinemia type III in an asymptomatic girl |
title_sort | tyrosinemia type iii in an asymptomatic girl |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471395/ https://www.ncbi.nlm.nih.gov/pubmed/28649543 http://dx.doi.org/10.1016/j.ymgmr.2015.10.004 |
work_keys_str_mv | AT szymanskaedyta tyrosinemiatypeiiiinanasymptomaticgirl AT sredzinskamalgorzata tyrosinemiatypeiiiinanasymptomaticgirl AT ciaraelzbieta tyrosinemiatypeiiiinanasymptomaticgirl AT piekutowskaabramczukdorota tyrosinemiatypeiiiinanasymptomaticgirl AT ploskirafal tyrosinemiatypeiiiinanasymptomaticgirl AT rokickidariusz tyrosinemiatypeiiiinanasymptomaticgirl AT tylkiszymanskaanna tyrosinemiatypeiiiinanasymptomaticgirl |